Cargando…
Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation
BACKGROUND: Tyrosine kinase inhibitors (TKIs) are effective therapies with demonstrated antineoplastic activity. Nilotinib is a second-generation FDA-approved TKI designed to overcome Imatinib resistance and intolerance in patients with chronic myelogenous leukemia (CML). Interestingly, TKIs have al...
Autores principales: | Contreras, Osvaldo, Villarreal, Maximiliano, Brandan, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819301/ https://www.ncbi.nlm.nih.gov/pubmed/29463296 http://dx.doi.org/10.1186/s13395-018-0150-5 |
Ejemplares similares
-
Resveratrol promotes myogenesis and hypertrophy in murine myoblasts
por: Montesano, Anna, et al.
Publicado: (2013) -
miR-487b-3p Suppresses the Proliferation and Differentiation of Myoblasts by Targeting IRS1 in Skeletal Muscle Myogenesis
por: Wang, Jian, et al.
Publicado: (2018) -
Serum from human burn victims impairs myogenesis and protein synthesis in primary myoblasts
por: Corrick, Katie L., et al.
Publicado: (2015) -
Myogenesis in the sea urchin embryo: the molecular fingerprint of the myoblast precursors
por: Andrikou, Carmen, et al.
Publicado: (2013) -
Fine-Tuning of Piezo1 Expression and Activity Ensures Efficient Myoblast Fusion during Skeletal Myogenesis
por: Ortuste Quiroga, Huascar Pedro, et al.
Publicado: (2022)